DMH1, a Small Molecule Inhibitor of BMP Type I Receptors, Suppresses Growth and Invasion of Lung Cancer

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin

(2013) Elaine Langenfeld et al.   Molecular Cancer

Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines

(2013) Elaine Langenfeld et al.   PLoS One

Cancer stem cells in lung cancer: Evidence and controversies

(2013) Muhammad Alamgeer et al.   RESPIROLOGY

BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells

(2011) Ulrike Maegdefrau et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer

(2011) Takayuki Kosaka et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Effects of the bone morphogenetic protein binding protein spp24 (secreted phosphoprotein 24 kD) on the growth of human lung cancer cells

(2011) Kwang-Bok Lee et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?

(2010) Emma-Leena Alarmo et al.   ENDOCRINE-RELATED CANCER

Bone Morphogenetic Proteins and Cancer

(2010) Jayesh P. Thawani et al.   NEUROSURGERY

In VivoStructure−Activity Relationship Study of Dorsomorphin Analogues Identifies Selective VEGF and BMP Inhibitors

(2009) Jijun Hao et al.   ACS Chemical Biology

Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway

(2008) Y Katsuno et al.   ONCOGENE